glp-1 gip vs tirzepatide Tirzepatide's Unique Mechanism of Action - GIP/GLP-1 Dual Agonist Tirzepatide vs. Semaglutide: What You

The battle over America's booming weight-loss drug market has a significant update, with a move thats likely to cause a shift across the healthcare and corporate benefits landscape: Cigna, one of Americas biggest insurers, is dropping coverage for GLP-1 obesity drugs, even for its own staff

By Vital Nutrients

One prescription, multiple diseases, and a cascade of transformative outcomes for the industry

GIP (Glucose-Dependent Insulinotropic Polypeptide) regulates insulin and lipid metabolism, linked to diabetes, obesity, and NAFLD

Lilly posted explosive 54% revenue growth powered by its GLP-1 obesity and diabetes drugs

Constipation on a GLP-1